Ann: Research Report on NuSep , page-3

FX
I talked to the relevant analyst after the last report in September. My comments are noted here on HotCopper previously and for what it is worth I for one found the report helpful.
I would submit that any potential new investor would get a useful overview of the IP and proposals for its deployment in the original report and the recent update.
Again as I have said before this is a SPECULATIVE stock. As you know I don't agree with everything (or even much of) what Syd & RB have posted here over time.... but I do agree with RB that this speculative stock has the POTENTIAL to build inter generational wealth! Of course the other side of the coin is that we could all lose our entire investment if the products fail at the trial stage and the company runs out of cash.
It is perfectly legitimate for a small speculative company such as ours to commission such a research report. One of the biggest problems we face is that NuSep just isn't on enough radar screens out there for the market to work as it should. With great respect I believe you are impugning the integrity of the broker and and the professional competence of the analyst if you are seriously suggesting that they just write (or paste in) whatever the client company wants them to say for a fee.
I know from your earlier posts that you are a long term investor who has seen the value of your initial stake seriously eroded over a period of years. Perhaps if you had the advantage of just such a report at the outset together with some professional advice, you may have a different view of the big picture today. I don't wish to be rude or patronising as you have made many valid points in the past (and I certainly don't resile from any of my posts on the need for our company to substantially improve its record on corporate governance) but there appears to me a lack of objectivity given your past experience as a shareholder. Things inevitably move on. I do think that any objective correspondent would now have to concede that substantial progress has been made over the last 12 months especially in Singapore and in particular that we now have a model that should protect shareholders from dilution.
Given this last comment you will understand that I am not ecstatic about the recent debt conversion announcement. I will however wait to see the detail before judging.
FX I really do think it is in all our interests i.e. all shareholder interests, that as many people as possible take a critical and informed look at NuSep with a view to investing. This update to the research report is one way to encourage that examination by small biotech fund managers and speculative investors alike.
BTW if we were on a lot more radar screens we would perhaps have been spared the ridiculous situation that arose earlier this morning when a trade of 500 shares for $22.50 in total was able to wipe >$600K of the value of our company (assuming my mental arithmetic is correct!)
FX why not take the time to phone the analyst and have a talk to him? When I last spoke to him he had a positive view of JM's ability to communictae what is a quite complex value proposition to the market. Who knows his insights may even convince you to average down your position in the company.
Kind regards,